Cas:18212-21-0 4-Methyl-1,2,3-thiadiazole-5-carboxylic acid manufacturer & supplier

We serve Chemical Name:4-Methyl-1,2,3-thiadiazole-5-carboxylic acid CAS:18212-21-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Methyl-1,2,3-thiadiazole-5-carboxylic acid

Chemical Name:4-Methyl-1,2,3-thiadiazole-5-carboxylic acid
CAS.NO:18212-21-0
Synonyms:4-Methyl-1,2,3-thiadiazole-5-carboxylic acid;4-methyl-5-hydroxycarbonyl-1,2,3-thiadiazole;5-carboxy-4-methyl-1,2,3-thiadiazole;1,2,3-Thiadiazole-5-carboxylic acid, 4-methyl-;4-methyl-1,2,3-thiadiazolyl-5-carboxylic acid;MFCD00173830
Molecular Formula:C4H4N2O2S
Molecular Weight:144.152
HS Code:2934999090

Physical and Chemical Properties:
Melting point:166 °C
Boiling point:315.2±34.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.608
PSA:91.32000
Exact Mass:143.999344
LogP:0.93

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-Methyl-1,2,3-thiadiazole-5-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00173830 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00173830 Use and application,4-methyl-5-hydroxycarbonyl-1,2,3-thiadiazole technical grade,usp/ep/jp grade.


Related News: Grégoire brings more than 20 years of technological innovation, strategy and digital entrepreneurship experience to the team. He started his career as the founder and CEO of Andrexen, an innovative Unified Communication Cloud Platform. 2-[(2-carboxy-4,5-dimethoxyphenyl)disulfanyl]-4,5-dimethoxybenzoic acid manufacturers For skin rash, the difference in response rates for anifrolumab versus placebo at week 52 were 13.5% SLE Disease Activity Index (SLEDAI), 15.5% British Isles Lupus Assessment Group index (BILAG) and 15.6% modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). For arthritis, differences in response rates were 8.2% SLEDAI, 11.8% BILAG and 12.6% joint response. 3-amino-6-methyl-tropolone suppliers Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. 2-(3-methyl-ureido)-benzothiazole-6-carboxylic acid ethyl ester vendor & factory.